Filing exhibits
- 8-K Current report
- 2.1 Exhibit 2.1
- 3.1 Exhibit 3.1
- 4.1 Exhibit 4.1
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 99.1 Latiglutenase is a potentially first-in-class oral biotherapeutic for the treatment of celiac disease
- Download Excel data file
- View Excel data file
Table of Contents